Li et al. experimented on nephrotic mice, comparing those without the ANGPTL-4 gene (using the CRISPR/Cas9 technique to eliminate the ANGPTL-4 gene) with mice that still had the gene, in terms of proteinuria and hyperlipidemia. This evidence concerns the gene ANGPTL4 and hyperlipidemia.